Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 hours agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 10 hours agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 5 hours agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 3 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 1 day agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support ...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 1 day agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 4 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 4 days agoModerna (NASDAQ: MRNA) jumped into the limelight when it started developing a coronavirus vaccine candidate. And the stock soared as the vaccine raced...